In vitro interaction between ceftazidime and vancomycin/teicoplanin in the presence of azithromycin against Pseudomonas aeruginosa

Barbara Repetto, Alberto Palenzona, Simone Cagnacci, Eugenio A. Debbia, Anna Marchese

Research output: Contribution to journalArticle

Abstract

Pseudomonas aeruginosa is an opportunistic pathogen, intrinsically resistant to many antibiotics and prone to acquire resistance against many drugs. It is assumed that agents that disorganise the structure of the outer membrane might allow the passage of other drugs into cell. To verify this hypothesis, ceftazidime (CAZ) has been tested in association with glycopeptides (GLYs) and azithromycin (AZI). Time-kill experiments were performed on a representative strain. CAZ in combination with GLYs showed 99, 90 and 10% of CFU/ml reduction in 33.9, 52.5 and 13.6% of the cases, respectively; the addition of AZI increased the incidence of 99% CFU/ml reduction to 42% of the cases. Indifference was the most common finding, and additive/synergism in the other cases. Present findings demonstrated that CAZ favourably reacted with GLYs in the presence of AZI.

Original languageEnglish
Pages (from-to)439-442
Number of pages4
JournalAnnals of Microbiology
Volume57
Issue number3
Publication statusPublished - 2007

Fingerprint

Teicoplanin
Azithromycin
Ceftazidime
Glycopeptides
Vancomycin
Pseudomonas aeruginosa
Pharmaceutical Preparations
Anti-Bacterial Agents
Membranes
Incidence
In Vitro Techniques

Keywords

  • Azithromycin
  • Ceftazidime
  • Drug combination
  • Pseudomonas aeruginosa
  • Selection of resistant strains
  • Time-kill tests
  • Vancomycin

ASJC Scopus subject areas

  • Microbiology
  • Biotechnology

Cite this

In vitro interaction between ceftazidime and vancomycin/teicoplanin in the presence of azithromycin against Pseudomonas aeruginosa. / Repetto, Barbara; Palenzona, Alberto; Cagnacci, Simone; Debbia, Eugenio A.; Marchese, Anna.

In: Annals of Microbiology, Vol. 57, No. 3, 2007, p. 439-442.

Research output: Contribution to journalArticle

Repetto, B, Palenzona, A, Cagnacci, S, Debbia, EA & Marchese, A 2007, 'In vitro interaction between ceftazidime and vancomycin/teicoplanin in the presence of azithromycin against Pseudomonas aeruginosa', Annals of Microbiology, vol. 57, no. 3, pp. 439-442.
Repetto, Barbara ; Palenzona, Alberto ; Cagnacci, Simone ; Debbia, Eugenio A. ; Marchese, Anna. / In vitro interaction between ceftazidime and vancomycin/teicoplanin in the presence of azithromycin against Pseudomonas aeruginosa. In: Annals of Microbiology. 2007 ; Vol. 57, No. 3. pp. 439-442.
@article{7610fc297c134ba0b315d1142b9cd438,
title = "In vitro interaction between ceftazidime and vancomycin/teicoplanin in the presence of azithromycin against Pseudomonas aeruginosa",
abstract = "Pseudomonas aeruginosa is an opportunistic pathogen, intrinsically resistant to many antibiotics and prone to acquire resistance against many drugs. It is assumed that agents that disorganise the structure of the outer membrane might allow the passage of other drugs into cell. To verify this hypothesis, ceftazidime (CAZ) has been tested in association with glycopeptides (GLYs) and azithromycin (AZI). Time-kill experiments were performed on a representative strain. CAZ in combination with GLYs showed 99, 90 and 10{\%} of CFU/ml reduction in 33.9, 52.5 and 13.6{\%} of the cases, respectively; the addition of AZI increased the incidence of 99{\%} CFU/ml reduction to 42{\%} of the cases. Indifference was the most common finding, and additive/synergism in the other cases. Present findings demonstrated that CAZ favourably reacted with GLYs in the presence of AZI.",
keywords = "Azithromycin, Ceftazidime, Drug combination, Pseudomonas aeruginosa, Selection of resistant strains, Time-kill tests, Vancomycin",
author = "Barbara Repetto and Alberto Palenzona and Simone Cagnacci and Debbia, {Eugenio A.} and Anna Marchese",
year = "2007",
language = "English",
volume = "57",
pages = "439--442",
journal = "Annals of Microbiology",
issn = "1590-4261",
publisher = "Springer Heidelberg",
number = "3",

}

TY - JOUR

T1 - In vitro interaction between ceftazidime and vancomycin/teicoplanin in the presence of azithromycin against Pseudomonas aeruginosa

AU - Repetto, Barbara

AU - Palenzona, Alberto

AU - Cagnacci, Simone

AU - Debbia, Eugenio A.

AU - Marchese, Anna

PY - 2007

Y1 - 2007

N2 - Pseudomonas aeruginosa is an opportunistic pathogen, intrinsically resistant to many antibiotics and prone to acquire resistance against many drugs. It is assumed that agents that disorganise the structure of the outer membrane might allow the passage of other drugs into cell. To verify this hypothesis, ceftazidime (CAZ) has been tested in association with glycopeptides (GLYs) and azithromycin (AZI). Time-kill experiments were performed on a representative strain. CAZ in combination with GLYs showed 99, 90 and 10% of CFU/ml reduction in 33.9, 52.5 and 13.6% of the cases, respectively; the addition of AZI increased the incidence of 99% CFU/ml reduction to 42% of the cases. Indifference was the most common finding, and additive/synergism in the other cases. Present findings demonstrated that CAZ favourably reacted with GLYs in the presence of AZI.

AB - Pseudomonas aeruginosa is an opportunistic pathogen, intrinsically resistant to many antibiotics and prone to acquire resistance against many drugs. It is assumed that agents that disorganise the structure of the outer membrane might allow the passage of other drugs into cell. To verify this hypothesis, ceftazidime (CAZ) has been tested in association with glycopeptides (GLYs) and azithromycin (AZI). Time-kill experiments were performed on a representative strain. CAZ in combination with GLYs showed 99, 90 and 10% of CFU/ml reduction in 33.9, 52.5 and 13.6% of the cases, respectively; the addition of AZI increased the incidence of 99% CFU/ml reduction to 42% of the cases. Indifference was the most common finding, and additive/synergism in the other cases. Present findings demonstrated that CAZ favourably reacted with GLYs in the presence of AZI.

KW - Azithromycin

KW - Ceftazidime

KW - Drug combination

KW - Pseudomonas aeruginosa

KW - Selection of resistant strains

KW - Time-kill tests

KW - Vancomycin

UR - http://www.scopus.com/inward/record.url?scp=35349007543&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=35349007543&partnerID=8YFLogxK

M3 - Article

AN - SCOPUS:35349007543

VL - 57

SP - 439

EP - 442

JO - Annals of Microbiology

JF - Annals of Microbiology

SN - 1590-4261

IS - 3

ER -